These findings suggest that the low expression of SHBG in the breast may be associated with the nine tumor-related pathways mentioned above, particularly alterations in p53/Rb-related pathway status and chromatin modifier status, thus confirming that low SHBG expression may be a risk factor for breast cancer development. Here, SHBG is linked to breast carcinoma.